… In this study, we evaluated risk factors for dry eye disease, intraocular pressure, and …
bronchodilators or corticosteroids via nebulizer but not inhaler is related to greater rates of dry eye. …

… It is advisable that an ophthalmologist consultation is sought for patients deemed to be at
risk for AACG before initiating on bronchodilator therapy. This may be feasible in selected …

… patients requiring inhaled bronchodilators during affection of … of the drugs, especially
albuterol. There also has been … the risk of transmission of infection directly from nebulization …

… Use of various drugs (other than bronchodilators and inhaled corticosteroids) by nebulized
… of aerosol leading to significant facial and eye deposition This risk is mitigated by using a …

… Inhaled medications have been used to treat pulmonary conditions for over 70 years.
Historically, inhaled therapies (bronchodilators, … provided in this article is solely at your own risk. …

… This study aimed to determine the reported risk of glaucoma, ocular hypertension (OHT) …
that assess ocular outcomes related to glaucoma in ICS and INS users. Study selection, risk of …

… probability that nebulizer treatments may increase the risk of … inhaled corticosteroids and
inhaled bronchodilators [11]. The GOLD strategy also recommends the use of bronchodilators …

… respirator and one without gloves, gown, or eye protection. None of the 103 HCWs tested for
… and unfiltered); 2.5 mL albuterol sulfate nebulized Aerosols measured by two aerodynamic …

… risk of respiratory and fungal infections, while the use of INCs was associated with a higher
risk of nasal and eye … it in combination with long-acting bronchodilators. But there might be …

… high risk of ocular hypertension or openangle glaucoma [odds ratio (OR)-1.44] in current
users of high doses of inhaled … The effect of nebulized bronchodilator therapy on intraocular …